navenibart Clinical Trials (2026): 3 Studies for Hereditary Angioedema (HAE) & Hereditary Angioedema
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
3 navenibart clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Hereditary Angioedema (HAE) & Hereditary Angioedema) and 319 total planned enrollment. 2 Phase 3 navenibart trials are listed. 2 navenibart clinical trials are actively recruiting. Most recent activity: NCT07204938 (Dec 2031).
navenibart clinical trials at a glance: phase × recruitment status
| Phase | enrolling by invitation | completed | Total |
|---|---|---|---|
| P1/P2 | 1 | 1 | |
| P3 | 2 | 2 |
Recruiting navenibart clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07204938 | A Long-Term Study of Navenibart in Participants With Hereditary Angioedema | P3 | Hereditary Angioedema (HAE) | 145 | Oct 2025 |
| NCT06842823 | ALPHA-ORBITA Study of Navenibart in Participants With Hereditary Angioedema | P3 | Hereditary Angioedema (HAE) | 145 | Mar 2025 |
navenibart clinical trials by indication
Hereditary Angioedema (HAE) (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07204938 | — | P3 | enrolling by invitation | A Long-Term Study of Navenibart in Participants With Hereditary Angioedema |
| NCT06842823 | ALPHA-ORBIT | P3 | enrolling by invitation | A Study of Navenibart in Participants With Hereditary Angioedema |
Hereditary Angioedema (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05695248 | STAR-0215 | P1/P2 | completed | A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema |
navenibart pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| ALPHA-ORBIT | NCT06842823 | P3 | enrolling by invitation | Hereditary Angioedema (HAE) | 145 | — |
All navenibart trials (3)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07204938 | A Long-Term Study of Navenibart in Participants With Hereditary Angioedema | P3 | enrolling by invitation | 145 | Astria Therapeutics, Inc. | Oct 2025 | |
| NCT06842823 | ALPHA-ORBIT | A Study of Navenibart in Participants With Hereditary Angioedema | P3 | enrolling by invitation | 145 | Astria Therapeutics, Inc. | Mar 2025 |
| NCT05695248 | STAR-0215 | A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema | P1/P2 | completed | 29 | Astria Therapeutics, Inc. | Feb 2023 |
navenibart clinical trials: frequently asked questions
- How many navenibart clinical trials are there?
- 3 navenibart clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants. 1 is marked completed.
- Are navenibart clinical trials recruiting in 2026?
- Yes — 2 navenibart trials are actively recruiting in 2026. See the recruiting trials and the per-state site list further down this page.
- What conditions is navenibart being studied for?
- navenibart is being studied for Hereditary Angioedema (HAE), Hereditary Angioedema. The trials are grouped by indication on this page.
- What phase is navenibart in?
- navenibart clinical trials span 2 Phase 3. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors navenibart clinical trials?
- The lead sponsor across the most navenibart trials is Astria Therapeutics, Inc.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming navenibartas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: